Bilaketaren emaitzak - Pan, Chun‐Hao

Dissecting the Oncogenic Roles of Keratin 17 in the Hallmarks of Cancer nork Baraks, Gabriella, Tseng, Robert, Pan, Chun-Hao, Kasliwal, Saumya, Leiton, Cindy V., Shroyer, Kenneth R., Escobar-Hoyos, Luisa F.

Testu osoa Testu osoa Testu osoa

Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells nork Pan, Chun-Hao, Chang, Ying-Fang, Lee, Ming-Shuo, Wen, B-Chen, Ko, Jen-Chung, Liang, Sheng-Kai, Liang, Mei-Chih

Testu osoa Testu osoa Testu osoa

Neutralizing activity to SARS‐CoV‐2 of convalescent and control plasma used in a randomized controlled trial nork Freedenberg, Alex T., Pan, Chun‐Hao, Diehl, William E., Romeiser, Jamie L., Hwang, Ga‐Ram, Leiton, Cindy V., Muecksch, Frauke, Shroyer, Kenneth R., Bennett‐Guerrero, Elliott

Testu osoa Testu osoa Testu osoa

Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer nork Roa-Peña, Lucia, Leiton, Cindy V., Babu, Sruthi, Pan, Chun-Hao, Vanner, Elizabeth A., Akalin, Ali, Bandovic, Jela, Moffitt, Richard A., Shroyer, Kenneth R., Escobar-Hoyos, Luisa F.

Testu osoa Testu osoa Testu osoa

An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer nork Pan, Chun‐Hao, Otsuka, Yuka, Sridharan, BanuPriya, Woo, Melissa, Leiton, Cindy V., Babu, Sruthi, Torrente Gonçalves, Mariana, Kawalerski, Ryan R., K. Bai, Ji Dong, Chang, David K., Biankin, Andrew V., Scampavia, Louis, Spicer, Timothy, Escobar‐Hoyos, Luisa F., Shroyer, Kenneth R.

Testu osoa Testu osoa Testu osoa

The PHLPP2 phosphatase is a druggable driver of prostate cancer progression nork Nowak, Dawid G., Katsenelson, Ksenya Cohen, Watrud, Kaitlin E., Chen, Muhan, Mathew, Grinu, D’Andrea, Vincent D., Lee, Matthew F., Swamynathan, Manojit Mosur, Casanova-Salas, Irene, Jibilian, Megan C., Buckholtz, Caroline L., Ambrico, Alexandra J., Pan, Chun-Hao, Wilkinson, John E., Newton, Alexandra C., Trotman, Lloyd C.

Testu osoa Testu osoa Testu osoa

Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer nork Escobar-Hoyos, Luisa F., Penson, Alex, Kannan, Ram, Cho, Hana, Pan, Chun-Hao, Singh, Rohit K., Apken, Lisa H., Hobbs, G. Aaron, Luo, Renhe, Lecomte, Nicolas, Babu, Sruthi, Pan, Fong Cheng, Alonso-Curbelo, Direna, Morris, John P., Askan, Gokce, Grbovic-Huezo, Olivera, Ogrodowski, Paul, Bermeo, Jonathan, Saglimbeni, Joseph, Cruz, Cristian D., Ho, Yu-Jui, Lawrence, Sharon A., Melchor, Jerry P., Goda, Grant A., Bai, Karen, Pastore, Alessandro, Hogg, Simon J., Raghavan, Srivatsan, Bailey, Peter, Chang, David K., Biankin, Andrew, Shroyer, Kenneth R., Wolpin, Brian M., Aguirre, Andrew J, Ventura, Andrea, Taylor, Barry, Der, Channing J., Dominguez, Daniel, Kümmel, Daniel, Oeckinghaus, Andrea, Lowe, Scott W., Bradley, Robert K., Abdel-Wahab, Omar, Leach, Steven D.

Testu osoa Testu osoa Testu osoa